Debiopharm is pleased to present its corporate film about our business model and accomplishments.
A bridge between the discovery of new molecules and their commercialisation
A biopharmaceutical development company that in-licenses promising biologics and small molecule drug candidates for global development
Applied research, drug delivery systems, FDA and SwissMedic inspected production facility
Financing of biotechnology and pharmaceutical start-ups to create synergies with Debiopharm Group
The financial arm of Debiopharm Group
Debiopharm Group™, founded in 1979, is a Swiss-based global biopharmaceutical group with a focus on drug development and companion diagnostics.
The group has brought five products to the market.
It possesses a wealth of development expertise and is financially independent.
More about us
All press releases
Debiopharm Group™ has been sponsoring two scientific awards for several years, one in Switzerland and one in Japan, namely:
Follow our latest Products Pipeline
Debiopharm Group presented At a glance
Social & Corporate Responsibility
We support Sarah Marquis' expedition